CME Group stock rises 1.4% as new options analytics tool launches, CME Group says

Traders Union
All News
Companies
CME Group gains 1.40% today

Highlights

CME Group trades above short-term averages but remains below key medium- and long-term resistance, showing conflicting momentum signals.
Technical indicators flag overbought conditions intraday despite waning trend strength, with volatility at 7.64% and CME topping its weekly range.
Expected trading range for the coming week is $242 to $260, with a higher probability of downward correction than further upside.

Short-term support builds as price stalls below key moving averages

CME Group is currently trading at $252.72, positioned well above the MA-20 ($237.01) but just below the MA-50 ($257.70), and considerably beneath the MA-200 ($278.76), reflecting short-term upward momentum with lingering medium- and long-term bearish pressure. The Ichimoku Kijun sits at $243.92, which lies below the current price and therefore acts as immediate support for the next moves; near-term support is clustered around the Kijun ($243.92) and MA-20, with key support at the MA-100 ($278.92), while the MA-50 ($257.70) provides the nearest resistance and the MA-200 stands as a key resistance zone.

Upside momentum fades as overbought signals and resistance converge

D1 momentum readings are mixed: ADX signals waning strength (Sell), and MACD suggests strong downside pressure (Strong Sell), while RSI remains modestly bullish at 53.19 and HMA continues to support buying activity. Overbought signals are flashing from CCI, Stoch RSI, and BBP on D1, with BBP showing a marked overbought phase indicating strong buyer dominance intraday. Weekly, CME has gained $7.67 (3.15%) from the previous close at $245.05, now sitting at the very top of its weekly range, as volatility stands at a moderate 7.64%. In today's session, CME is up 1.4%, pushing against the weekly resistance after a steady recovery from the prior week’s low.

Bearish reversal risk grows as upside scenarios recede

Looking ahead, the anticipated range for the coming week is $242 to $260, which aligns with the historical volatility and keeps price action realistic within 7% of the current level. This corridor leaves CME well clear of its 52-week low ($218.31) but distant from the 52-week high ($329.16). The probability of further upside is very low (less than 20%), while a downward correction is more likely as indicated by bearish signals from MA-50-W1, RSI-W1, ADX-W1, and MACD-W1. The baseline scenario expects CME to consolidate between $242 and $260. A bullish scenario could see a close above $260 if buyers break resistance, while a bearish case may trigger a slide toward $243 if the support cluster fails.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that CME Group had shifted toward a bullish outlook, with improving fundamentals and technicals supporting buyer dominance and the potential for a breakout. The current analysis expands on this by evaluating the latest market developments, with investors advised to monitor for any tests of key resistance that could signal a new phase of price momentum.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.